Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP290583.RAd2kcoL4zBfXkWX0a_Ws8327kUhs_FjHkBNZvf2_ka6Y130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290583.RAd2kcoL4zBfXkWX0a_Ws8327kUhs_FjHkBNZvf2_ka6Y130_provenance.
• assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP642211.RAfX9Av5BuJnNmQIFyKCSzBCqEANEYMkgZH5mq5TLxViY130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642211.RAfX9Av5BuJnNmQIFyKCSzBCqEANEYMkgZH5mq5TLxViY130_provenance.
• NP710120.RAZyfrG0CC_LVS-cZudWmxLa4kf_PW0UZHpnMqIazJLyg130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710120.RAZyfrG0CC_LVS-cZudWmxLa4kf_PW0UZHpnMqIazJLyg130_provenance.
• assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1135848.RAWCRlS8YeZUh3pMlC6Rgshk8cJtFg_RrHa5hag6ZciNQ130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135848.RAWCRlS8YeZUh3pMlC6Rgshk8cJtFg_RrHa5hag6ZciNQ130_provenance.
• NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135850.RAe3nf6ZAkK_xjFec68CEF1DvW7rS6r_mKtEwx7kRGAdU130_provenance.
• NP1135852.RAdhacPjRekx1UjnAE9RsDrDYu9npgPCqu7teR71Bi3iA130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135852.RAdhacPjRekx1UjnAE9RsDrDYu9npgPCqu7teR71Bi3iA130_provenance.
• NP1135855.RAbAG0zVVHnmaG6xewU_ICtSxMbYdZWnzuGbpJ6BN9AUI130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135855.RAbAG0zVVHnmaG6xewU_ICtSxMbYdZWnzuGbpJ6BN9AUI130_provenance.
• NP838386.RAg6MRc6jpIQxcMSRiOmbl4StAgNwkPHQB9kyLIPDcpWk130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838386.RAg6MRc6jpIQxcMSRiOmbl4StAgNwkPHQB9kyLIPDcpWk130_provenance.
• NP1135847.RAlkmR4XMMSbrKu6vYlasaleIS5DIuP_sR0yPIgN5wTXc130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135847.RAlkmR4XMMSbrKu6vYlasaleIS5DIuP_sR0yPIgN5wTXc130_provenance.
• NP1135851.RAvHnmE_Ym5YnwV3P_PSMuzFtiXUIaPpPh9pChqcmY5-s130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135851.RAvHnmE_Ym5YnwV3P_PSMuzFtiXUIaPpPh9pChqcmY5-s130_provenance.
• NP338536.RA9f-8_on3NQkNyFlZYMZ8pUddqxcHDkAJl8umI_K3Mv4130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338536.RA9f-8_on3NQkNyFlZYMZ8pUddqxcHDkAJl8umI_K3Mv4130_provenance.
• NP282823.RAzVu9TQXgF6bnDPWareuHvsz9Y9XNZ2K9hLbiRhmzCNE130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282823.RAzVu9TQXgF6bnDPWareuHvsz9Y9XNZ2K9hLbiRhmzCNE130_provenance.
• NP252564.RAyTMkkP72YK-QK5ZiK54b1G_OyjPQkLfpmu7qvugMj_M130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252564.RAyTMkkP72YK-QK5ZiK54b1G_OyjPQkLfpmu7qvugMj_M130_provenance.
• NP833705.RA674kA0U04A6lykZuqMRU0kDRiqBWNVMUQi5sQ0u-zB0130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833705.RA674kA0U04A6lykZuqMRU0kDRiqBWNVMUQi5sQ0u-zB0130_provenance.
• NP1005027.RALp2gYSFlPRKRFaSM4kYFuKRtclNDFq4jvp8iV94OwFQ130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005027.RALp2gYSFlPRKRFaSM4kYFuKRtclNDFq4jvp8iV94OwFQ130_provenance.
• NP1135854.RAGhEIHHbvFBIqieV9As0icjV-UrRYfgjQm1vDPEBr4Ek130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135854.RAGhEIHHbvFBIqieV9As0icjV-UrRYfgjQm1vDPEBr4Ek130_provenance.
• NP1135853.RAxqx-41qGUakmhyA-kGfyZJ7s_zNueKM9dKWY6cBlVOU130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135853.RAxqx-41qGUakmhyA-kGfyZJ7s_zNueKM9dKWY6cBlVOU130_provenance.
• NP1135856.RA7rslXRnqfNiTzYgKMmxVmBgJA07T6E6lgiQlDqjVFv4130_assertion description "[T-cell therapy is one such area where recent trials using T cells genetically modified to express an antibody-based chimeric antigen receptor (CAR) targeted against the CD19 antigen have demonstrated impressive responses when adoptively transferred to patients with advanced chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135856.RA7rslXRnqfNiTzYgKMmxVmBgJA07T6E6lgiQlDqjVFv4130_provenance.